autoimmune disorder
| 10+ min read
Researchers develop gluten-degrading enzymes to administer as drugs or incorporate into food and explore therapies that block downstream disease checkpoints.
| 5 min read
A group of researchers leveraged their location to tackle questions about the rare autoimmune disorder, Addison’s disease.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe